Literature DB >> 6420164

Pharmacological interaction between nitroglycerin and aspirin after acute and chronic aspirin treatment of healthy subjects.

E Rey, H D El-Assaf, M O Richard, S Weber, A Bourdon, G Picard, G Olive.   

Abstract

The interaction between nitroglycerin (NTG) and aspirin was investigated in 7 healthy subjects in order to test whether aspirin could block the haemodynamic response to NTG; the doses used were NTG 0.8 mg, and aspirin 0.5 g for chronic and 1 g for acute treatment. The plasma levels of NTG and various physiological parameters (heart rate, diastolic arterial pressure, end diastolic diameter, and end systolic diameter) were measured during the 30 minutes after the administration of NTG. An increase in NTG Cmax and AUC was observed after both aspirin treatment. The changes in physiological parameters produced by NTG were enhanced by the two treatments, although the differences were not statistically significant. The results indicate complex pharmacokinetic and pharmacodynamic interactions between NTG and aspirin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6420164     DOI: 10.1007/bf00542519

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Glyceryl trinitrate in angina pectoris.

Authors:  G SANDLER; M A ILAHI; C W LAWSON
Journal:  Lancet       Date:  1963-05-25       Impact factor: 79.321

2.  [Plasma levels of nitroglycerin after oral and percutaneous administration (author's transl)].

Authors:  C Girre; J Crouzette; P E Fournier
Journal:  Nouv Presse Med       Date:  1980-09-25

3.  Relation of time course of plasma nitroglycerin levels to echocardiographic, arterial pressure and heart rate changes after sublingual administration of nitroglycerin.

Authors:  J Y Wei; P R Reid
Journal:  Am J Cardiol       Date:  1981-10       Impact factor: 2.778

4.  Difference in nitroglycerin dose-response in the venous and arterial beds.

Authors:  P R Imhof; B Ott; P Frankhauser; L C Chu; J Hodler
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

5.  Plasma nitroglycerin levels after sublingual, oral and topical administration.

Authors:  H P Blumenthal; H L Fung; E F McNiff; S K Yap
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

6.  Effect of inhibitors of prostaglandin synthesis on hepatic drug clearance.

Authors:  J Feely; A J Wood
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

7.  Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction.

Authors:  H K Gold; R C Leinbach; C A Sanders
Journal:  Circulation       Date:  1972-11       Impact factor: 29.690

8.  Quantitative determination of trinitroglycerin in human plasma.

Authors:  J Y Wei; P R Reid
Journal:  Circulation       Date:  1979-03       Impact factor: 29.690

9.  Inhibition of platelet prostaglandin synthetase by oral aspirin.

Authors:  J W Burch; N Stanford; P W Majerus
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

10.  Responses to arachidonic acid and other dilator agonists and their modification by inhibition of prostaglandin synthesis in the canine hindlimb.

Authors:  E Morcillo
Journal:  J Pharm Pharmacol       Date:  1980-05       Impact factor: 3.765

View more
  4 in total

1.  The effects of moderate sustained exercise on the pharmacokinetics of nitroglycerine.

Authors:  S Weber; D de Lauture; E Rey; T Darragon; J P Severins; A Ditisheim; G Olive; M Degeorges
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.

Authors:  M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

3.  The role of vascular endothelium in nitroglycerin-mediated vasodilation.

Authors:  Kangbin Zhou; John D Parker
Journal:  Br J Clin Pharmacol       Date:  2018-12-03       Impact factor: 4.335

4.  Nitroglycerin disposition in human blood.

Authors:  P A Cossum; M S Roberts
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.